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Summary The average number of nucleolar organiser regions per cell has previously been shown to correlate
well with histological grading techniques for a variety of neoplasms in man, and may thus be of value as an
aid to post-surgical prognosis. In this study 50 spontaneously arising, subcutaneous canine mast cell tumours
were graded and the histological grade compared with the mean AgNOR count. For well differentiated
neoplasms the mean count was 1.4 per cell compared with 6.3 for poorly differentiated neoplasms, while
tumours of intermediate differentiation had a mean count of 3.2 per cell. Subsequent follow up studies
revealed that the AgNOR count was an accurate prognostic indicator, 73% of dogs with a high mean count
(greater than 4.9) being destroyed from tumour related disease compared with 33% with an intermediate
count (1.7-4.8). No dog with a count of less than 1.7 has been destroyed because of tumour recurrence to
date and the AgNOR count has proved to be a better and more objective prognostic indicator than either
histological tumour grade or mitotic index. Since most dogs which develop recurrent mast cell tumours do so
within 6 months of initial surgery, an assessment of the predictive value of AgNORs can be obtained more
quickly in canine tumours than for comparable human neoplasms.
Cutaneous mast cell tumours are the most common histolo-
gically confirmed skin neoplasms of dogs in many parts of
the world (Bostock, 1986) and are usually amenable to
surgical ablation when first presented. It has been shown
that, for animals with no clinical evidence of residual tumour
immediately following removal, behaviour is closely related
to histological grade. Thus, well differentiated tumours carry
a favourable prognosis and poorly differentiated lesions a
very guarded prognosis (Bostock, 1973; Patnaik et al., 1984).
Many tumours, however, fall into an intermediate category
in which the prognosis is more difficult to predict, with
estimates of tumour related deaths varying between 20 and
50% (Bostock, 1986). Furthermore, the grading of mast cell
tumours, particularly those of intermediate differentiation, is
somewhat subjective, and there is marked discrepancy in the
proportions of the various grades between series from differ-
ent authors (Table I).
Nucleolar organiser regions are present in the nucleus of
all cells, where they act as the sites for transcription of
rRNA. They can be visualised readily in either impression
smears or formalin fixed, routinely processed paraffin
sections because of their close association with proteins
containing a large number of disulphide bonds, which bind
to silver ions (Smith et al., 1988). They are, therefore,
usually referred to as AgNORs when stained in this way.
Crocker and his colleagues have shown that the average
number of AgNORs per nucleus correlates well with histolo-
gical grading methods for a variety of human neoplasms,
including lymphomas (Crocker & Nar, 1987), mammary
tumours (Smith & Crocker, 1988) and melanomas (Crocker
& Skilbeck, 1987) while others (Derenzini et al., 1988) have
similarly demonstrated an increased number in intestinal
adenocarcinomas compared with hyperplastic polyps.
In view of these correlations we considered that the
number of AgNORs might be of value as a prospective
indicator of prognosis in canine mast cell tumours, particu-
larly in view of their ease of demonstration and objectivity
of measurement.
In dogs, most mast cell tumours which are destined to kill
their host do so within 6 months of initial excision as a
result either of inoperable local recurrence in the scar, or
lymphatic metastasis (Bostock, 1973) so that an assessment
of predictive value for AgNORs should be obtained much
sooner in dogs than for comparable human neoplasms in
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which follow-up studies in excess of 5 years are normally
required.
Materials and methods
Spontaneously arising subcutaneous mast cell tumours were
excised by veterinary surgeons in general practice, fixed in
formal saline and submitted for histological examination.
Data supplied at the time of submission included the breed,
sex and age of the dog, the site and size of the tumour and a
clinical assessment of tumour stage. Representative portions
of each neoplasm were processed in the usual way and
stained with haematoxylin and eosin. Following a diagnosis
of mast cell tumour, 3gm paraffin sections were prepared,
stained with the silver colloid method previously described
(Ploton et al., 1986) and the number of AgNORs in 100 cells
counted under oil immersion (x 1,000), in random nuclei.
This technique of enumeration can now be regarded as
standard, and is preferable to the use of image analysis
systems which are often unable to distinguish between
adjacent AgNOR dots (Crocker et al., 1989a).
Tumours were sub-divided histologically into well differen-
tiated, intermediate and poorly differentiated grades using
the criteria described previously (Bostock, 1973) and the
mitotic index was assessed by counting the number of cells
in mitosis in 10 high power fields at x 400 magnification,
selected at random. All tumours were graded, and mitotic
indices assessed before the AgNOR count was known.
All dogs in clinical stage To No Mo (Owen, 1980)
immediately after surgery were followed up at 8 week
intervals by means of telephone interviews with the referring
veterinary surgeon and owner, and the presence of recur-
rence, intercurrent disease or death noted. The cause of
death was ascertained by the referring veterinarian. No dogs
were allowed to die naturally and where death is referred to
in the text or tables it indicates euthanasia in response to
inoperable local recurrence or disseminated metastases.
Results
Fifty dogs with histologically confirmed mast cell tumours
which showed no clinical evidence of residual tumour imme-
diately after surgery were followed up until death, or for a
minimum of 9 months.
Nineteen tumours were well differentiated histologically,
16 were intermediate and 15 poorly differentiated, the mean
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Table I Distribution of tumour grades in histologically evaluated spontaneous mast cell tumours
Number of dogs (%) with
Well Poorly
Author Year differentiated Intermediate differentiated Total
Hottendorf & Neilsen 1967 161 (54) 82 (27) 57 (19) 300
Bostock 1973 39 (34) 30 (26) 45 (40) 114
Patnaik et al. 1984 17 (20) 36 (44) 30 (36) 83
AgNOR counts per cell in the three groups being 1.4, 3.2
and 6.3 respectively (Figures 1 and 2). The difference
between each of these was significant at the P=0.0001 level
(Student's t test, Table II).
The AgNOR count varied from an average of 1.1 to 8.1
per cell, the relationship between the quintiles of these
counts, median survival time and tumour related death rate
being shown in Table III. From this it can be seen that the
dogs fell into three distinct groups in terms of both tumour
related deaths and median survival time. Animals with a
count of 4.9 or above had a poor prognosis, with 3/4 dying
as a direct result of the tumour within the first 4 months
after surgery. Those with intermediate counts, between 1.7
and 4.8, had a better prognosis although about 1/3 were
destroyed because of tumour related disease, while no dog
with a count of less than 1.7 has been destroyed because of
the tumour to date.
Figure 1 Well differentiated mast cell tumour.
contain 1-3 AgNORs ( x 700).
Most nuclei
Figure 2 Poorly differentiated mast cell tumour.
contain multiple small AgNORs ( x 700).
When the animals were divided into high and low count
groups, the former consisting of dogs with a count of 4 or
more and the latter those with a count less than 4, there was
a highly significant difference in both survival time and
tumour related death rate (Table IV), so that for general
prognostic purposes division into these two groups would be
adequate.
The mitotic index of some canine tumours is known to be
of prognostic significance. The survival time of dogs with
mast cell tumours in relation to the mitotic index of the
primary neoplasm is shown in Table V. The index varied
from 0 to 64 but there was no significant difference between
animals with tumours of mitotic index 0-4 or 5-10. How-
ever, tumour related death rates were significantly worse
(P<0.05, X2) for dogs with tumours of mitotic index greater
than 10. Two-thirds of the dogs with lesions of high mitotic
index were destroyed because of tumour related disease
compared with 1/4 animals with low mitotic index tumours.
It is generally recognised that canine mast cell tumours
have a marked breed predisposition, with boxers and Labra-
dor retrievers being over-represented in most surveys, and
that the prognosis for boxers is generally better than that for
other breeds. This is, however, entirely due to the relatively
high proportion of well differentiated tumours in boxers, and
tumours of similar grade carry the same prognosis, regard-
less of breed (Bostock, 1973). This is further illustrated in
Table VI, by the very close similarity in AgNOR count
between tumours of the same grade, regardless of breed.
Discussion
In man, it has generally been found that AgNORs are
greater in number (and smaller in size) in high-grade than
low-grade malignant neoplasms. In most species, NORs are
restricted to a constant number of acrocentric chromosomes
and it would be anticipated that, with increasing ploidy,
AgNOR numbers would be elevated. However, it has been
shown, by means of DNA flow cytometry, that there is no
relation between NOR numbers and DNA ploidy in human
lymphomas (Crocker et al., 1988). Conversely, in the same
study, a close correlation between NOR numbers and
percentage S phase cells was found, suggesting that NOR
numbers are related to cellular proliferation. A high positive
correlation between AgNOR numbers and the number of
cells labelled by the proliferation-marking monoclonal anti-
body, Ki67, has also been demonstrated (Hall et al., 1988).
Furthermore, it has recently been shown that individual
human lymphoid cells with a high AgNOR count are also Ki
67 positive (Crocker et al., 1989c).
In addition, lymphomas with high interphase NOR counts
do not necessarily possess an excess of metaphase NORs on
chromosomes, whilst specimens with low interphase AgNOR
numbers often have hyperdiploid chromosomal complements
and excessive metaphase AgNORs (Crocker et al., 1989b),
again illustrating the lack of correlation between interphase
and metaphase or chromosomal NOR counts.
NOR numbers have also been shown to reflect cellular
differentiation experimentally. When a human promyelocytic
leukaemia cell line (HL60) was induced to differentiate to
granulocyte-like cells by dimethylsulphoxide, the number of
AgNORs diminished (Reeves et al., 1984). While it is still
uncertain whether an increase in interphase NOR number is
fundamentally associated with neoplastic transformation, the Many nucleiNUCLEOLAR ORGANISERS IN MAST CELL TUMOURS 917
Table II Correlation between tumour grade, AgNOR count and survival time for dogs
with spontaneous mast cell tumour
Mean Median Number
Number AgNOR survival (%) dead
Histological of dogs count time from
grade (%) (range) (weeks) tumour
Well differentiated 19 (38) 1.4 40a 2 (10)
(1.1-3.5)
Intermediate 16 (32) 3.2 36a 4 (25)
(2.5-4.2)
Poorly differentiated 15 (30) 6.3 13 11 (73)
(5.1-8.1)
aMedian dog still alive at time of writing.
Table III Quintiles of AgNOR counts in relation to survival time and cause of death for
dogs with spontaneous mast cell tumours
Median Dead Still
survival from alive at
No. of time tumour Significance of time of
Count dogs (weeks) (%) difference (X2) writing
6.5-8.1 4 5 3 (75) 1
4.9-6.4 11 17 8 (72) p<0.05 3
3.3-4.8 7 36a 2 (35) 5
1.7-3.2 13 36a 4 (32) 14
<1.7 15 62a 4 (3) P<0.05 14
Total 50 17 (34) 30b
aMedian dog still alive at time of writing; bThree dogs were destroyed because of unrelated
disease, without evidence of tumour recurrence.
Table IV The relationship between AgNOR count, median survival time and
tumour death rate in dogs with spontaneous mast cell tumours
Median Number
survival deadfrom
No. of time tumour
Count dogs (weeks) (%)
>4 18 17 12 (66)
P<0.01 P=0.001
(rank sum test) (X2 test)
<4 32 soa 5 (15)
aMedian dog still alive at the time of writing.
Table V The relationship between survival time tumour related
death rate and mitotic index for dogs with spontaneous mast cell
tumours
Median No. dead
Mitotic No. of survival time from tumour
index dogs (weeks) (%)
0-4 35 40a 8 (23)
5-10 4 40a 1 (25)
>10 11 11 8 (72)
aMedian dog still alive at time of writing.
Table VI The relationship between breed of dog and AgNOR count for tumours of the same
grade
Mean count for grade
Well Poorly
Breed No. of dogs differentiated Intermediate differentiated
Boxer 10 1.5 3.0 6.7
Labrador/retriever 21 1.4 3.0 6.5
Other pure breed 10 1.3 3.8 6.4
Cross bred 9 1.7 3.1 5.8918 D.E. BOSTOCK et al.
strong correlation with both cellular differentiation and
malignant behaviour demonstrated in this study suggests that
this may be so.
Although these results again reveal three different groups
of mast cell tumour which are closely correlated with tumour
grade, the objectivity of the method should greatly enhance
grading and enable those dogs which require prophylactic
post-surgical therapy to be identified with more certainty.
A further advantage of the technique is its ready appli-
cation to cytological preparations, which are extremely diffi-
cult to grade using conventional stains. The value of the
method has been demonstrated in the differentiation of
malignant cells from reactive in patients with pleural
effusions (Ayres et al., 1988) and an evaluation of its use in
needle aspirates from canine mast cell tumours is currently
being undertaken.
The observation that mitotic index is of prognostic signi-
ficance is also of interest, although this feature alone is a
relatively insensitive measure of behaviour for tumours of
lower mitotic index. Some lesions with high AgNOR counts
had a low mitotic index and their behaviour was more
accurately predicted by the AgNOR count than the mitotic
index.
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